- Report of Foreign Issuer (6-K)
20 10월 2012 - 5:12AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
______________________
FORM 6-K
______________________
Report of Foreign
Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For
the month of October 2012
Commission File Number:
000-28508
Flamel Technologies,
S.A.
(Translation of registrant's
name into English)
Parc Club du Moulin
à Vent
33 avenue du Dr. Georges
Levy
69693 Vénissieux
Cedex France
(Address of principal
executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Indicate by check mark whether registrant by furnishing the
information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under
the Securities Exchange Act of 1934.
If "Yes"
is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-____________
In October 2012, Flamel
Technologies issued the press release attached hereto as Exhibit 99.1 and incorporated herein by reference.
EXHIBIT LIST
Exhibit
Number
|
|
Description
|
99.1
|
|
Press release announcing FDA acceptance of New Drug Application
|
|
|
|
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
Dated: October 19, 2012
|
Flamel Technologies, S.A.
|
|
|
|
|
|
|
By:
|
/s/ Michael S. Anderson
|
|
Name: Michael S. Anderson
|
|
Title: Chief Executive Officer
|
EXHIBIT INDEX
Exhibit
Number
|
|
Description
|
99.1
|
|
Press release announcing FDA acceptance of New Drug Application
|
|
|
|
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Avadel Pharmaceuticals (NASDAQ:AVDL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024